PR-Section 8 and 9

TRILIPIX

ABBVIE INC.

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1963 (Rev 05/2006)
OMB No. 0651-0055 (Exp 10/31/2021)

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


The table below presents the data as entered.

Input Field
Entered
REGISTRATION NUMBER 3587733
REGISTRATION DATE 03/10/2009
SERIAL NUMBER 77116366
MARK SECTION
MARK TRILIPIX (see, http://uspto.report/TM/77116366/mark.png)
ATTORNEY SECTION (current)
NAME Cheryl A. Withycombe
FIRM NAME AbbVie Inc.
STREET 1 N. Waukegan Road
CITY North Chicago
STATE Illinois
POSTAL CODE 60064
COUNTRY United States
PHONE 847-937-3386
FAX 847-938-2623
EMAIL trademarks@abbvie.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
ATTORNEY SECTION (proposed)
NAME Cheryl A. Withycombe
FIRM NAME AbbVie Inc.
INTERNAL ADDRESS AP34-2/V377
STREET 1 N. Waukegan Road
CITY North Chicago
STATE Illinois
POSTAL CODE 60064
COUNTRY United States
PHONE 847-937-3386
FAX 847-938-2623
EMAIL trademarks@abbvie.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER T51187
CORRESPONDENCE SECTION (current)
NAME Cheryl A. Withycombe
FIRM NAME AbbVie Inc.
STREET 1 N. Waukegan Road
CITY North Chicago
STATE Illinois
POSTAL CODE 60064
COUNTRY United States
PHONE 847-937-3386
FAX 847-938-2623
EMAIL trademarks@abbvie.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
CORRESPONDENCE SECTION (proposed)
NAME Cheryl A. Withycombe
FIRM NAME AbbVie Inc.
INTERNAL ADDRESS AP34-2/V377
STREET 1 N. Waukegan Road
CITY North Chicago
STATE Illinois
POSTAL CODE 60064
COUNTRY United States
PHONE 847-937-3386
FAX 847-938-2623
EMAIL trademarks@abbvie.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
DOCKET/REFERENCE NUMBER T51187
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
GOODS OR SERVICES Pharmaceutical preparations for the treatment of cardiovascular disorders
       SPECIMEN FILE NAME(S)
       JPG FILE(S) \\TICRS\EXPORT17\IMAGEOUT 17\771\163\77116366\xml2\ S890002.JPG
       ORIGINAL PDF FILE SPN0-15918013212-20190305175720668475_._TRILIPIX_PI_030519.pdf
       CONVERTED PDF FILE(S)
       (20 pages)
\\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890003.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890004.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890005.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890006.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890007.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890008.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890009.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890010.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890011.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890012.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890013.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890014.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890015.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890016.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890017.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890018.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890019.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890020.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890021.JPG
        \\TICRS\EXPORT17\IMAGEOUT17\771\163\77116366\xml2\S890022.JPG
SPECIMEN DESCRIPTION Digital image of product packaging and PDF of prescribing information.
OWNER SECTION (current)
NAME ABBVIE INC.
INTERNAL ADDRESS 1 N. WAUKEGAN RD.
STREET DEPT. V377, BLDG. AP34-2
CITY NORTH CHICAGO
STATE Illinois
ZIP/POSTAL CODE 60064
COUNTRY United States
OWNER SECTION (proposed)
NAME ABBVIE INC.
INTERNAL ADDRESS 1 N. WAUKEGAN RD.
STREET DEPT. V377, BLDG. AP34-2
CITY NORTH CHICAGO
STATE Illinois
ZIP/POSTAL CODE 60064
COUNTRY United States
PHONE 847-937-3386
FAX 847-938-2623
EMAIL XXXX
AUTHORIZED TO COMMUNICATE VIA E-MAIL Yes
LEGAL ENTITY SECTION (current)
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
PAYMENT SECTION
NUMBER OF CLASSES 1
NUMBER OF CLASSES PAID 1
COMBINED §§ 8 & 9 DECLARATION/APPLICATION FILING FEE 425
TOTAL FEE PAID 425
SIGNATURE SECTION
SIGNATURE /Cheryl A. Withycombe/
SIGNATORY'S NAME Cheryl A. Withycombe
SIGNATORY'S POSITION Attorney of Record, IL Bar Member
DATE SIGNED 03/06/2019
SIGNATORY'S PHONE NUMBER 847-937-3386
PAYMENT METHOD DA
FILING INFORMATION
SUBMIT DATE Thu Mar 07 08:36:32 EST 2019
TEAS STAMP USPTO/S08N09-XXX.XXX.XXX.
XX-20190307083632526388-3
587733-620585076741e20491
5a1496014a65a87b1f97bf1e5
336da47c2f136c2e7598eb8c-
DA-10484-2019030517572066
8475



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1963 (Rev 05/2006)
OMB No. 0651-0055 (Exp 10/31/2021)


Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


To the Commissioner for Trademarks:

REGISTRATION NUMBER: 3587733
REGISTRATION DATE: 03/10/2009

MARK: TRILIPIX

The owner, ABBVIE INC., a corporation of Delaware, having an address of
      1 N. WAUKEGAN RD.
      DEPT. V377, BLDG. AP34-2
      NORTH CHICAGO, Illinois 60064
      United States
      847-937-3386
      847-938-2623
      XXXX (authorized)
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.

For International Class 005, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registration for this specific class: Pharmaceutical preparations for the treatment of cardiovascular disorders ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) Digital image of product packaging and PDF of prescribing information..
JPG file(s):
Specimen File1
Original PDF file:
SPN0-15918013212-20190305175720668475_._TRILIPIX_PI_030519.pdf
Converted PDF file(s) (20 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Specimen File7
Specimen File8
Specimen File9
Specimen File10
Specimen File11
Specimen File12
Specimen File13
Specimen File14
Specimen File15
Specimen File16
Specimen File17
Specimen File18
Specimen File19
Specimen File20
The registrant's current Attorney Information: Cheryl A. Withycombe of  AbbVie Inc.
      1 N. Waukegan Road
      North Chicago, Illinois 60064
      United States
The phone number is 847-937-3386.
The fax number is 847-938-2623.
The email address is trademarks@abbvie.com. (authorized)

The registrant's proposed Attorney Information: Cheryl A. Withycombe of  AbbVie Inc.
      AP34-2/V377
      1 N. Waukegan Road
      North Chicago, Illinois 60064
      United States The docket/reference number is T51187.

The phone number is 847-937-3386.
The fax number is 847-938-2623.
The email address is trademarks@abbvie.com. (authorized)
The registrant's current Correspondence Information: Cheryl A. Withycombe of  AbbVie Inc.
      1 N. Waukegan Road
      North Chicago, Illinois 60064
      United States
The phone number is 847-937-3386.
The fax number is 847-938-2623.
The email address is trademarks@abbvie.com. (authorized)

The registrant's proposed Correspondence Information: Cheryl A. Withycombe of  AbbVie Inc.
      AP34-2/V377
      1 N. Waukegan Road
      North Chicago, Illinois 60064
      United States The docket/reference number is T51187.

The phone number is 847-937-3386.
The fax number is 847-938-2623.
The email address is trademarks@abbvie.com. (authorized)

A fee payment in the amount of $425 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.


Declaration

Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods/services or to indicate membership in the collective membership organization identified above, as evidenced by the attached specimen(s).
Unless the owner has specifically claimed excusable nonuse, the specimen(s) shows the mark as currently used in commerce on or in connection with the goods/services/collective membership organization.
The registrant requests that the registration be renewed for the goods/services/collective organization identified above.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of this submission and the registration, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /Cheryl A. Withycombe/    Date: 03/06/2019
Signatory's Name: Cheryl A. Withycombe
Signatory's Position: Attorney of Record, IL Bar Member
Signatory's Phone: 847-937-3386

Mailing Address (current):
   AbbVie Inc.
   1 N. Waukegan Road
   North Chicago, Illinois 60064

Mailing Address (proposed):
   AbbVie Inc.
   1 N. Waukegan Road
   North Chicago, Illinois 60064

Serial Number: 77116366
Internet Transmission Date: Thu Mar 07 08:36:32 EST 2019
TEAS Stamp: USPTO/S08N09-XXX.XXX.XXX.XX-201903070836
32526388-3587733-620585076741e204915a149
6014a65a87b1f97bf1e5336da47c2f136c2e7598
eb8c-DA-10484-20190305175720668475

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed